Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma

Abstract

GDC-0449, an orally active small molecule that targets the hedgehog pathway, appears to have antitumor activity in locally advanced or metastatic basal-cell carcinoma. (ClinicalTrials.gov number, NCT00607724.)